The health of Mette Marit from Norway worries again due to the effects of her treatment

Concern for the health of the princess Mette-Marit has increased after the Norwegian Royal Family announced that he is on sick leave due to the side effects of his medical treatment.

While this situation occurs in the midst of the scandal that his eldest son is facing, Marius Borgafter he was accused of physically and psychologically attacking a young woman on August 4. Which has caused two of his ex-partners to also accuse him of using violence against them.

Princess Mette-Marit suspended her official agenda

Let us remember that since 2018 the wife of Prince Haakon fights against a rare chronic disease called pulmonary fibrosis. That is why a few days ago the monarchical institution itself reported that the 51-year-old royal would undergo treatment due to this condition.

While this Wednesday the Royal House of Norway issued a brief statement, through social networksin which he points out that Mette-Marit will be out and will not attend scheduled public events for the following days.

Crown Princess Mette-Marit is on sick leaveinitially for a week. This means, among other things, that he will not attend tomorrow’s government dinner at the Royal Palace,” the message reads.

“Due to the side effects of the medications that the Crown Princess has to take for her chronic lung disease, she has been hospitalized, initially for a week,” according to the same statement, which also clarifies that the acts or events that the royal had scheduled for that period “will be canceled or postponed.”

However, this situation was something that unfortunately could be seen coming since when it was reported that he would resume his treatment, it was also warned that this could cause side effects that would alter his official agenda. Something that, unfortunately, has already happened.

What is pulmonary fibrosis?

On the other hand, the pulmonary fibrosis It is a chronic disease that affects the lungs, causing scarring (fibrosis) in the lung tissue, which hardens and thickens the walls of the alveoli, the small air sacs where oxygen exchange occurs.

This scarring process hinders the lungs’ ability to function properly, affecting their ability to oxygenate the blood. Over time, breathing becomes more difficult and less efficient, which can lead to a progressive decrease in quality of life.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *